Imaging Mass Spectrometry (IMS), a peptide biomarker discovery tool using tissue [ 2011 - 2013 ]

Research Grant

[Cite as]

Researchers Hoffmann Dr Peter; Prof Shaun R McColl; Dr Matthias Pelzing

Brief description Cancer is the second most common cause of death in Australia. The newly developed technology of Imaging Mass Spectrometry for peptides in tissue has the potential to discover biomarkers for early diagnosis of cancer. This new technology could avoid a number of cancer deaths and reduce suffering of patients through earlier and better diagnosis.

Funding Amount $180,000

Funding Scheme Linkage Projects

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]